A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France

NCT07451002 · clinicaltrials.gov ↗

RECRUITING

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms
Metastatic Hormone-sensitive Prostate Cancer

Sponsor

Janssen Cilag S.A.S.